Company Filing History:
Years Active: 1987-1989
Title: Masaaki Yokoyama: Innovator in Cephalosporin Compounds
Introduction
Masaaki Yokoyama is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cephalosporin compounds. With a total of 3 patents to his name, Yokoyama's work has had a notable impact on antibacterial agents.
Latest Patents
Yokoyama's latest patents include innovative cephalosporin compounds and processes for their preparation. One of his notable inventions is a cephalosporin compound characterized by a specific formula, where R1 can be a hydrogen atom, a halogen atom, a methoxy group, or various other chemical groups. This compound is designed to enhance the efficacy of antibacterial treatments. Another patent focuses on a similar cephalosporin compound, again emphasizing its potential as an antibacterial agent.
Career Highlights
Masaaki Yokoyama is currently associated with Kaken Pharmaceutical Company, Ltd., where he continues to advance his research in pharmaceutical innovations. His work has been instrumental in developing new antibacterial agents that can combat resistant strains of bacteria.
Collaborations
Yokoyama has collaborated with notable colleagues in his field, including Takanobu Naito and Yoshiyuki Zama. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Masaaki Yokoyama's contributions to the field of cephalosporin compounds highlight his role as a key innovator in pharmaceuticals. His patents reflect a commitment to advancing medical science and improving health outcomes.